Astrana Health (ASTH) Equity Income (2017 - 2026)

Astrana Health (ASTH) has 10 years of Equity Income data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Equity Income rose 298.39% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (up 44.51% YoY) and the FY2025 annual result came in at $1.7 million, down 61.63% from the prior year.
• Equity Income improved to $1.7 million in Q1 2026 per ASTH's latest filing, from $1.2 million in the prior quarter.
• The five-year high for Equity Income was $2.7 million in Q2 2023, with the low at -$2.1 million in Q3 2023.
• Average Equity Income over 5 years is $1.1 million, with a median of $1.4 million recorded in 2024.
• Year-over-year, Equity Income surged 311.67% in 2022 and slumped 244.9% in 2023.
• Astrana Health's Equity Income stood at $1.2 million in 2022, then surged by 102.04% to $2.5 million in 2023, then sank by 37.33% to $1.6 million in 2024, then slipped by 24.18% to $1.2 million in 2025, then surged by 46.26% to $1.7 million in 2026.
• Business Quant data shows ASTH's Equity Income at $1.7 million in Q1 2026, $1.2 million in Q4 2025, and $1.0 million in Q3 2025.